iMICROQ (Integrated Microsystems for Quality of Life, S.L.), a Tarragona, Spain-based provider of a detection and identification system of pathogenic agents, raised €1.1m in funding.
The round was led by Caixa Capital Risc, which made the via its fund focused on Caixa Capital BioMed, its biotechnology and medical technologies, with participation from a group of business angels.
According to its web site, the company intends to use the funds to accelerate international validation activities, as well as industrial and production tests to start the international commercialization of the kit for rapid detection of Salmonella spp (QFast Salmonella).
IMICROQ was founded in 2010 by Ioanis Katakis, Pablo Lozano, Diego Bejarano, Maria Viviana Duarte and Carlos Arias with the aim of commercially exploit the technology for the production of integrated screen printed microsystems of low cost, easy and quick to use, which was developed at the University Rovira i Virgili (Tarragona), in the research centre Advanced Innovation Technology Centre, ATIC.